High number of HPAI H5 virus infections and antibodies in wild carnivores in the Netherlands, 2020-2022.


Journal

Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 3 11 2023
pubmed: 16 10 2023
entrez: 16 10 2023
Statut: ppublish

Résumé

In October 2020, a new lineage of a clade 2.3.4.4b HPAI virus of the H5 subtype emerged in Europe, resulting in the largest global outbreak of HPAI to date, with unprecedented mortality in wild birds and poultry. The virus appears to have become enzootic in birds, continuously yielding novel HPAI virus variants. The recently increased abundance of infected birds worldwide increases the probability of bird-mammal contact, particularly in wild carnivores. Here, we performed molecular and serological screening of over 500 dead wild carnivores and sequencing of RNA positive materials. We show virological evidence for HPAI H5 virus infection in 0.8%, 1.4%, and 9.9% of animals tested in 2020, 2021, and 2022 respectively, with the highest proportion of positives in foxes, polecats and stone martens. We obtained near full genomes of 7 viruses and detected PB2 amino acid substitutions known to play a role in mammalian adaptation in three sequences. Infections were also found in without neurological signs or mortality. Serological evidence for infection was detected in 20% of the study population. These findings suggests that a high proportion of wild carnivores is infected but undetected in current surveillance programmes. We recommend increased surveillance in susceptible mammals, irrespective of neurological signs or encephalitis.

Identifiants

pubmed: 37842795
doi: 10.1080/22221751.2023.2270068
doi:

Substances chimiques

Antibodies 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2270068

Auteurs

Irina V Chestakova (IV)

Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.

Anne van der Linden (A)

Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.

Beatriz Bellido Martin (B)

Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.

Valentina Caliendo (V)

Dutch Wildlife Health Centre, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.

Oanh Vuong (O)

Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.

Sanne Thewessen (S)

Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.

Tijmen Hartung (T)

Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.

Theo Bestebroer (T)

Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.

Jasja Dekker (J)

Jasja Dekker Dierecologie B.V., Arnhem, The Netherlands.

Bob Jonge Poerink (B)

Ecosensys, Zuurdijk, The Netherlands.

Andrea Gröne (A)

Dutch Wildlife Health Centre, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
Division of Pathology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.

Marion Koopmans (M)

Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.

Ron Fouchier (R)

Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.

Judith M A van den Brand (JMA)

Dutch Wildlife Health Centre, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
Division of Pathology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.

Reina S Sikkema (RS)

Department of Viroscience, ErasmusMC, Rotterdam, The Netherlands.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH